|Bid||15.78 x 4000|
|Ask||15.88 x 4000|
|Day's range||15.81 - 15.92|
|52-week range||10.91 - 17.20|
|Beta (5Y monthly)||1.12|
|PE ratio (TTM)||7.73|
|Forward dividend & yield||0.37 (2.33%)|
|Ex-dividend date||13 Apr 2021|
|1y target est||18.56|
(Bloomberg) -- A UBS Group AG trader sued his employer over allegations the “toxic” London work environment and “punishing workload” caused his mental health to deteriorate so far he was no longer able to work.Most Read from BloombergIstanbul Turns Taps on Old Fountains, Joining Global Push for Free DrinksThe Global Housing Market Is Broken, and It’s Dividing Entire CountriesIn Paris, the Wrapped Arc de Triomphe Is a Polarizing PackageHow the Child Care Crisis Became a Global Economic FiascoMerk
The heavy selling pressure might have exhausted for UBS (UBS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
NEW YORK, September 20, 2021--UBS Investment Bank today announced the recent listing of two new ETNs linked to the IFED Large-Cap US Equity Index TR, which are specified in the table below.